These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Regulation of histone methylation by automethylation of PRC2. Wang X; Long Y; Paucek RD; Gooding AR; Lee T; Burdorf RM; Cech TR Genes Dev; 2019 Oct; 33(19-20):1416-1427. PubMed ID: 31488576 [TBL] [Abstract][Full Text] [Related]
28. PRC2.1 and PRC2.2 Synergize to Coordinate H3K27 Trimethylation. Healy E; Mucha M; Glancy E; Fitzpatrick DJ; Conway E; Neikes HK; Monger C; Van Mierlo G; Baltissen MP; Koseki Y; Vermeulen M; Koseki H; Bracken AP Mol Cell; 2019 Nov; 76(3):437-452.e6. PubMed ID: 31521505 [TBL] [Abstract][Full Text] [Related]
29. Structural basis for PRC2 engagement with chromatin. Glancy E; Ciferri C; Bracken AP Curr Opin Struct Biol; 2021 Apr; 67():135-144. PubMed ID: 33232890 [TBL] [Abstract][Full Text] [Related]
30. H2A Ubiquitination Alters H3-tail Dynamics on Linker-DNA to Enhance H3K27 Methylation. Ohtomo H; Ito S; McKenzie NJ; Uckelmann M; Wakamori M; Ehara H; Furukawa A; Tsunaka Y; Shibata M; Sekine SI; Umehara T; Davidovich C; Koseki H; Nishimura Y J Mol Biol; 2023 Feb; 435(4):167936. PubMed ID: 36610636 [TBL] [Abstract][Full Text] [Related]
31. Jarid2 Methylation via the PRC2 Complex Regulates H3K27me3 Deposition during Cell Differentiation. Sanulli S; Justin N; Teissandier A; Ancelin K; Portoso M; Caron M; Michaud A; Lombard B; da Rocha ST; Offer J; Loew D; Servant N; Wassef M; Burlina F; Gamblin SJ; Heard E; Margueron R Mol Cell; 2015 Mar; 57(5):769-783. PubMed ID: 25620564 [TBL] [Abstract][Full Text] [Related]
32. PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation. Ren Z; Ahn JH; Liu H; Tsai YH; Bhanu NV; Koss B; Allison DF; Ma A; Storey AJ; Wang P; Mackintosh SG; Edmondson RD; Groen RWJ; Martens AC; Garcia BA; Tackett AJ; Jin J; Cai L; Zheng D; Wang GG Blood; 2019 Oct; 134(14):1176-1189. PubMed ID: 31383640 [TBL] [Abstract][Full Text] [Related]
33. A mutation in the E(Z) methyltransferase that increases trimethylation of histone H3 lysine 27 and causes inappropriate silencing of active Polycomb target genes. Stepanik VA; Harte PJ Dev Biol; 2012 Apr; 364(2):249-58. PubMed ID: 22182520 [TBL] [Abstract][Full Text] [Related]
34. An Evolutionary Conserved Epigenetic Mark of Polycomb Response Elements Implemented by Trx/MLL/COMPASS. Rickels R; Hu D; Collings CK; Woodfin AR; Piunti A; Mohan M; Herz HM; Kvon E; Shilatifard A Mol Cell; 2016 Jul; 63(2):318-328. PubMed ID: 27447986 [TBL] [Abstract][Full Text] [Related]
35. Dissecting the role of H3K27 acetylation and methylation in PRC2 mediated control of cellular identity. Lavarone E; Barbieri CM; Pasini D Nat Commun; 2019 Apr; 10(1):1679. PubMed ID: 30976011 [TBL] [Abstract][Full Text] [Related]
37. Recent Structural Insights into Polycomb Repressive Complex 2 Regulation and Substrate Binding. Kasinath V; Poepsel S; Nogales E Biochemistry; 2019 Feb; 58(5):346-354. PubMed ID: 30451485 [TBL] [Abstract][Full Text] [Related]
38. Polycomb-like 2 regulates PRC2 components to affect proliferation in glioma cells. Wang F; Gao Y; Lv Y; Wu Y; Guo Y; Du F; Wang S; Yu J; Cao X; Li PA J Neurooncol; 2020 Jun; 148(2):259-271. PubMed ID: 32436117 [TBL] [Abstract][Full Text] [Related]
39. The role of EZH1 and EZH2 in development and cancer. Lee SH; Li Y; Kim H; Eum S; Park K; Lee CH BMB Rep; 2022 Dec; 55(12):595-601. PubMed ID: 36476271 [TBL] [Abstract][Full Text] [Related]
40. A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin. Chen S; Jiao L; Liu X; Yang X; Liu X Mol Cell; 2020 Mar; 77(6):1265-1278.e7. PubMed ID: 31959557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]